Helene Merle-Beral

Title: Helene Merle-Beral: Innovator in Cancer Treatment

Introduction

Helene Merle-Beral is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions. With a total of 2 patents, her work focuses on the use of soluble peptides in combating cancer.

Latest Patents

Merle-Beral's latest patents include a method and pharmaceutical composition for use in the treatment of cancer. The invention relates to a soluble peptide comprising the amino acid sequence: KRFYVVMWKK (SEQ ID NO:1) or a function-conservative variant thereof. This invention also encompasses a pharmaceutical composition that includes at least one soluble peptide, one acid nucleic, one expression vector, or one host cell, along with a pharmaceutically acceptable carrier.

Career Highlights

Throughout her career, Helene Merle-Beral has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Pierre et Marie Curie. Her research has been pivotal in advancing the understanding and treatment of cancer.

Collaborations

Some of her notable coworkers include Santos A. Susin and Pierre Launay. Their collaborative efforts have contributed to the success of her research initiatives.

Conclusion

Helene Merle-Beral's innovative work in cancer treatment exemplifies the impact of dedicated research in the medical field. Her contributions continue to inspire advancements in pharmaceutical science.